4.8 Article

Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression

Journal

CELL REPORTS
Volume 39, Issue 5, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2022.110766

Keywords

-

Categories

Funding

  1. RUCCTS [UL1 TR001866, R01 AR078268-01A1]
  2. Robertson Foundation
  3. Bernard and Irene Schwartz Foundation
  4. University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002001]
  5. Bertha and Louis Weinstein research fund
  6. Accelerating Medicines Partnership (AMP) in RA and SLE Network
  7. National Institutes of Health [UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694, UM2-AR067678]
  8. [R21 AR071670]

Ask authors/readers for more resources

A population of synovial B cells that co-express a family of orphan nuclear receptors has been identified, which plays an important role in local adaptive immune responses in rheumatoid arthritis (RA) synovial tissue.
Ectopic lymphoid structures (ELS) can develop in rheumatoid arthritis (RA) synovial tissue, but the precise pathways of B cell activation and selection are not well understood. Here, we identify a synovial B cell population characterized by co-expression of a family of orphan nuclear receptors (NR4A1-3), which is highly enriched in RA synovial tissue. A transcriptomic profile of NR4A synovial B cells significantly overlaps with germinal center light zone B cells and an accrual of somatic hypermutation that correlates with loss of naive B cell state. NR4A B cells co-express lymphotoxins a and b and IL-6, supporting functions in ELS promotion. Expanded and shared clones between synovial NR4A B cells and plasma cells and the rapid upregulation with BCR stimulation point to in situ differentiation. Together, we identify a dynamic progression of B cell activation in RA synovial ELS, with NR4A transcription factors having an important role in local adaptive immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann, Elisabetta Sciacca, Cankut cubuk, Giovanni Giorli, Christopher R. John, Alessandra Nerviani, Liliane Fossati-Jimack, Georgina Thorborn, Manzoor Ahmed, Edoardo Prediletto, Sarah E. Church, Briana M. Hudson, Sarah E. Warren, Paul M. McKeigue, Frances Humby, Michele Bombardieri, Michael R. Barnes, Myles J. Lewis, Costantino Pitzalis

Summary: This study analyzes the biomarkers of the R4RA trial and identifies pretreatment synovial biopsy features that are selectively associated with the response to rituximab or tocilizumab in patients with rheumatoid arthritis. The study develops machine learning algorithms that can predict treatment response and highlights the importance of incorporating molecular pathology signatures into clinical algorithms for optimizing the use of existing medications and developing new drugs for refractory patients.

NATURE MEDICINE (2022)

Article Rheumatology

2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

Susan M. Goodman, Bryan D. Springer, Antonia F. Chen, Marshall Davis, David R. Fernandez, Mark Figgie, Heather Finlayson, Michael D. George, Jon T. Giles, Jeremy Gilliland, Brian Klatt, Ronald MacKenzie, Kaleb Michaud, Andy Miller, Linda Russell, Alexander Sah, Matthew P. Abdel, Beverly Johnson, Lisa A. Mandl, Peter Sculco, Marat Turgunbaev, Amy S. Turner, Adolph Yates, Jasvinder A. Singh

Summary: This study developed updated guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases undergoing elective total hip arthroplasty or elective total knee arthroplasty. The guidelines include recommendations for the use of traditional disease-modifying antirheumatic drugs, biologic agents, targeted synthetic small-molecule drugs, and glucocorticoids for the treatment of patients with inflammatory arthritis or systemic lupus erythematosus.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells

Anja Meyer, Ryan E. Sienes, Wes Nijim, Brian Zanotti, Sadiq Umar, Michael V. Volin, Katrien Van Raemdonck, Myles Lewis, Costantino Pitzalis, Shiva Arami, Mina Al-Awqati, Huan J. Chang, Pim Jetanalin, Georg Schett, Nadera Sweiss, Shiva Shahrara

Summary: The study found that syntenin-1 is enriched in rheumatoid arthritis (RA) specimens compared to osteoarthritis synovial fluid and normal synovial tissue. However, the cellular origin, immunoregulation and molecular mechanism of syntenin-1 in RA are still unknown.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Editorial Material Rheumatology

Progress continues in prediction of the response to treatment of RA

Myles J. Lewis, Costantino Pitzalis

Summary: In 2022, significant progress was made in predicting treatment response in rheumatoid arthritis. This was achieved through gene-expression profiling in synovial biopsy samples, assessment of interferon-response genes in the blood, and the application of machine learning to patients' clinical parameters and genetic variance.

NATURE REVIEWS RHEUMATOLOGY (2023)

Review Immunology

Single-cell computational machine learning approaches to immune-mediated inflammatory disease: New tools uncover novel fibroblast and macrophage interactions driving pathogenesis

Douglas Fritz, Jun Inamo, Fan Zhang

Summary: Recent advances in single-cell sequencing technologies have revealed the heterogeneity of fibroblasts and their potential clinical significance in inflammatory diseases. Computational techniques, including machine learning, have played a crucial role in categorizing fibroblast subpopulations and their interactions with other immune cells. These computational omics approaches have the potential to contribute to therapeutic strategies for inflammatory diseases by targeting fibroblast-macrophage interactions.

FRONTIERS IN IMMUNOLOGY (2023)

Article Orthopedics

Black Patients are More Likely to Undergo Early Revision Total Knee Arthroplasty in a Matched Cohort Regardless of Surgeon Experience

Serene Z. Mirza, Yi Zhang, Huong T. Do, Bella Mehta, Susan M. Goodman, Anne R. Bass

Summary: Black patients have a higher risk of aseptic revision TKA compared to White patients, and this disparity is not related to surgeon characteristics.

JOURNAL OF ARTHROPLASTY (2023)

Article Immunology

Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis

Melanie H. Smith, Vianne R. Gao, Preethi K. Periyakoil, Alejandro Kochen, Edward F. DiCarlo, Susan M. Goodman, Thomas M. Norman, Laura T. Donlin, Christina S. Leslie, Alexander Y. Rudensky

Summary: Smith et al. provide a detailed resource on the factors driving transcriptional heterogeneity of synovial fibroblasts during rheumatoid arthritis. The study explores the communication between immigrant and resident cell types in human inflammatory disease, highlighting the role of local exposure to cytokines in driving distinct fibroblast states. These findings enhance our understanding of the inflamed synovium and its contribution to disease progression.

NATURE IMMUNOLOGY (2023)

Article Rheumatology

Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis

Bella Mehta, Deanna Jannat-Khah, Katherine Kayla Glaser, Yiming Luo, Lisa R. Sammaritano, D. Ware Branch, Susan M. Goodman, Michael Lockshin, Fei Wang, Said Ibrahim, Jane E. Salmon

Summary: The study aimed to evaluate and quantify the indicators of fetal and maternal morbidity in deliveries for patients with systemic lupus erythematosus (SLE) compared with deliveries in patients without SLE. The findings showed that patients with SLE had a higher risk of fetal morbidity, including intrauterine growth restriction (IUGR) and preterm delivery, than patients without SLE. During delivery, mothers with SLE were at a higher risk of severe maternal morbidity, including blood transfusion, cerebrovascular disorders, and acute renal failure, compared to those without SLE. These results have important implications for guiding and counseling SLE patients during pregnancy and planning.

RMD OPEN (2023)

Article Rheumatology

Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis

Nilasha Ghosh, Pankti Reid, Carlos Andres Aude, Jessica Kirschman, Susan Goodman, Vivian P. Bykerk, Amit Lakhanpal, Diviya Rajesh, Karmela K. Chan, William H. Robinson, Anne R. Bass

Summary: In this study, the expansion of ACPA epitopes in CCP+ICI-IA was compared with patients with RA. It was found that patients with ICI-IA had lower ACPA titres and targeted fewer ACPA epitopes compared to longstanding RA patients, and there were no significant differences in the presence of the shared epitope between ICI-IA patients and ICI controls. This suggests that ICI-IA may represent an accelerated model of RA pathogenesis.

RMD OPEN (2023)

Review Biochemistry & Molecular Biology

DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

Susan Siyu Wang, Myles J. Lewis, Costantino Pitzalis

Summary: Rheumatoid arthritis (RA) is a complex disease with heterogeneity in disease severity and treatment response. Current prediction methods for treatment response have limitations, and genetics and environmental factors alone cannot fully explain the differences between patients. Recent studies have shown that DNA methylation plays a role in the pathogenesis and progression of RA, and specific DNA methylation profiles in the blood may serve as predictive biomarkers. This review examines the evidence for DNA methylation signatures in treatment response and discusses the potential for future progress in this area.

BIOMEDICINES (2023)

Article Medicine, Research & Experimental

Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production

Shyamala Thirunavukkarasu, Mushtaq Ahmed, Bruce A. Rosa, Mark Boothby, Sung Hoon Cho, Javier Rangel-Moreno, Stanley K. Mbandi, Valerie Schreiber, Ananya Gupta, Joaquin Zuniga, Makedonka Mitreva, Deepak Kaushal, Thomas J. Scriba, Shabaana A. Khader

Summary: PARP9 mRNA is upregulated in TB patients and mice, and PARP9 plays a critical regulatory role in DNA damage, cGAS expression, and type I IFN production during TB. Parp9-deficient mice are susceptible to Mycobacterium tuberculosis infection with increased TB disease, cGAS and cGAMP expression, and type I IFN production, along with upregulation of complement and coagulation pathways. The increased TB susceptibility is type I IFN dependent, and blockade of IFNAR signaling reverses the enhanced susceptibility of Parp9-/- mice. In contrast to its enhancement of type I IFN production in viral infections, this member of the MAR family, PARP9, plays a protective role by limiting type I IFN responses during TB.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Rheumatology

Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation

Bella Mehta, Susan Goodman, Edward DiCarlo, Deanna Jannat-Khah, J. Alex B. Gibbons, Miguel Otero, Laura Donlin, Tania Pannellini, William H. H. Robinson, Peter Sculco, Mark Figgie, Jose Rodriguez, Jessica M. M. Kirschmann, James Thompson, David Slater, Damon Frezza, Zhenxing Xu, Fei Wang, Dana E. E. Orange

Summary: This study aimed to differentiate osteoarthritis (OA) and rheumatoid arthritis (RA) by examining hematoxylin and eosin (H&E)-stained synovial tissue samples. OA patients exhibited increased mast cells and fibrosis, while RA patients showed increased lymphocytic inflammation, lining hyperplasia, neutrophils, detritus, plasma cells, binucleate plasma cells, sub-lining giant cells, fibrin, Russell bodies, and synovial lining giant cells. Combining pathologist scores with cell density metrics improved the classification accuracy.

ARTHRITIS RESEARCH & THERAPY (2023)

Article Cell Biology

Network-based cytokine inference implicates Oncostatin M as a driver of an inflammation phenotype in knee osteoarthritis

Hirotaka Iijima, Fan Zhang, Fabrisia Ambrosio, Yusuke Matsui

Summary: This study demonstrates the role of inflammatory cytokines in cartilage degradation and the impact of aging on this process. It identifies Oncostatin M as a driver of aberrant matrix remodeling and highlights high-value targets for drug development and repurposing in treating knee osteoarthritis.

AGING CELL (2023)

Article Rheumatology

Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcome

Katriona Goldmann, Athina Spiliopoulou, Andrii Iakovliev, Darren Plant, Nisha Nair, Cankut Cubuk, Paul McKeigue, Michael R. Barnes, Anne Barton, Costantino Pitzalis, Myles J. Lewis

Summary: This study conducted expression quantitative trait locus (eQTL) analysis using RNA-Sequencing to explore the link between genetic variants and gene expression in rheumatoid arthritis (RA) patients. The analysis identified 898 eQTL genes in synovium and blood, with 232 genes in common. A specific eQTL at HLA-DPB2 was found to be associated with clinical severity and the lympho-myeloid pathotype.

ANNALS OF THE RHEUMATIC DISEASES (2023)

No Data Available